172 related articles for article (PubMed ID: 17563741)
21. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia.
Jung AS; Holman PR; Castro JE; Carrier EK; Bashey A; Lane TA; Nelson CL; Pu M; Messer K; Corringham SM; Ball ED
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1306-13. PubMed ID: 19747639
[TBL] [Abstract][Full Text] [Related]
22. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Damon LE; Rugo HS; Ries CA; Linker CA
Bone Marrow Transplant; 1996 Jan; 17(1):93-9. PubMed ID: 8673063
[TBL] [Abstract][Full Text] [Related]
23. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
24. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial.
Breems DA; Boogaerts MA; Dekker AW; Van Putten WL; Sonneveld P; Huijgens PC; Van der Lelie J; Vellenga E; Gratwohl A; Verhoef GE; Verdonck LF; Löwenberg B
Br J Haematol; 2005 Jan; 128(1):59-65. PubMed ID: 15606550
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
Smith FO; Alonzo TA; Gerbing RB; Woods WG; Arceci RJ;
Leukemia; 2005 Dec; 19(12):2054-62. PubMed ID: 16136168
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.
Hale GA; Heslop HE; Bowman LC; Rochester RA; Pui CH; Brenner MK; Krance RA
Bone Marrow Transplant; 1999 Oct; 24(7):735-9. PubMed ID: 10516676
[TBL] [Abstract][Full Text] [Related]
27. Stage-specific application of allogeneic and autologous marrow transplantation in the management of acute myeloid leukemia.
Edenfield WJ; Gore SD
Semin Oncol; 1999 Feb; 26(1):21-34. PubMed ID: 10073559
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission.
Quah TC; Yeoh AE; Sun L
Singapore Med J; 1997 Aug; 38(8):344-6. PubMed ID: 9364889
[TBL] [Abstract][Full Text] [Related]
30. Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation.
Simonsson B; Tötterman T; Hokland P; Lauria F; Carella AM; Fernandez MN; Rozman C; Ferrant A; de Witte T; Zander AR; Meier K; Hansson F; Nilsson BI
Bone Marrow Transplant; 2000 Jun; 25(11):1121-7. PubMed ID: 10849523
[TBL] [Abstract][Full Text] [Related]
31. Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission.
Kim HJ; Min WS; Eom KS; Park SJ; Park YH; Kim DW; Lee JW; Park CW; Kim CC
Bone Marrow Transplant; 2004 Aug; 34(3):215-20. PubMed ID: 15170169
[TBL] [Abstract][Full Text] [Related]
32. Impact of cytogenetics on the outcome of autotransplantation for acute myeloid leukemia in first remission: is the benefit of intensive pretransplant therapy limited to patients with good karyotypes?
Mehta J; Powles R; Sirohi B; Treleaven J; Swansbury GJ; Kulkarni S; Saso R; Singhal S
Bone Marrow Transplant; 2003 Jul; 32(2):157-64. PubMed ID: 12838280
[TBL] [Abstract][Full Text] [Related]
33. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic versus autologous versus peripheral stem cell transplantation in CR1 pediatric AML patients: a single center experience.
Anak S; Saribeyoglu ET; Bilgen H; Unuvar A; Karakas Z; Devecioglu O; Agaoglu L; Gedikoglu G
Pediatr Blood Cancer; 2005 Jun; 44(7):654-9. PubMed ID: 15700262
[TBL] [Abstract][Full Text] [Related]
35. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
Ribera JM; Ortega JJ; Oriol A; Bastida P; Calvo C; Pérez-Hurtado JM; González-Valentín ME; Martín-Reina V; Molinés A; Ortega-Rivas F; Moreno MJ; Rivas C; Egurbide I; Heras I; Poderós C; Martínez-Revuelta E; Guinea JM; del Potro E; Deben G
J Clin Oncol; 2007 Jan; 25(1):16-24. PubMed ID: 17194902
[TBL] [Abstract][Full Text] [Related]
36. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F; Bisogno G; Collini P; Jenkner A; Gandola L; D'Angelo P; Casazza G; Piva L; Luksch R; Perotti D; Pession A; Fagioli F; Dallorso S
Pediatr Blood Cancer; 2008 Jul; 51(1):23-8. PubMed ID: 18293386
[TBL] [Abstract][Full Text] [Related]
37. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO; Wilmot F; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2007 Jan; 13(1):1-25. PubMed ID: 17222748
[TBL] [Abstract][Full Text] [Related]
38. ABMT for children AML: Italian experience. GITMO-AIEOP Groups.
Meloni G; Vignetti M; Andrizzi C; Dallorso S; Bonetti F; Zanesco L; Madon E; Andolina M; Carella AM; De Laurenzi A
Bone Marrow Transplant; 1991; 7 Suppl 3():80-3. PubMed ID: 1855095
[TBL] [Abstract][Full Text] [Related]
39. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
